The pitfalls in cytology diagnosis of poorly differentiated neuroendocrine carcinoma of lung and their treatment response | Zendy

Debarshi Saha | Zendy; Ankit Kumar | Zendy; Sourjya Banerjee | Zendy; M Nirupama | Zendy; Sridevi Hanaganahalli Basavaiah | Zendy; Priya Garg | Zendy; Flora D. Lobo | Zendy

Open Access

The pitfalls in cytology diagnosis of poorly differentiated neuroendocrine carcinoma of lung and their treatment response

Author(s) -

Debarshi Saha,

Ankit Kumar,

Sourjya Banerjee,

M Nirupama,

Sridevi Hanaganahalli Basavaiah,

Priya Garg,

Flora D. Lobo

Publication year - 2017

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.192761

Subject(s) - histopathology , medicine , cytology , adenocarcinoma , biopsy , carcinoma , etoposide , medical diagnosis , lung , radiology , cytopathology , small cell carcinoma , pathology , chemotherapy , cancer

Lung is the most common site of small cell carcinoma (SCLC) - a poorly differentiated neuroendocrine carcinoma (PDNEC). SCLC comprises 15-20% of the invasive cancers of the lung.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog